title: Massive erythrophagocytosis by peripheral monocytes and neutrophils in parvovirus-B19 autoimmune hemolytic anemia.
authors.affiliation: Technical University of Catalonia, Barcelona, Spain.
authors.forename: Laura
authors.initials: L
authors.lastname: Puigví
authors.affiliation: Department of Hematology, Hospital Clínic of Barcelona, Barcelona, Spain.
authors.forename: Tycho
authors.initials: T
authors.lastname: Baumann
authors.affiliation: Medical Intensive Care Unit, IDIBAPS, Hospital Clínic of Barcelona, University of Barcelona, Barcelona, Spain.
authors.forename: Sara
authors.initials: S
authors.lastname: Fernández
authors.affiliation: Medical Intensive Care Unit, IDIBAPS, Hospital Clínic of Barcelona, University of Barcelona, Barcelona, Spain.
authors.forename: Pedro
authors.initials: P
authors.lastname: Castro
authors.affiliation: Biomedical Diagnostic Center, Hospital Clínic of Barcelona, Villarroel, 170, 08036, Barcelona, Spain.
authors.forename: Arturo
authors.initials: A
authors.lastname: Pereira
authors.affiliation: Biomedical Diagnostic Center, Hospital Clínic of Barcelona, Villarroel, 170, 08036, Barcelona, Spain. amerino@clinic.cat.
authors.forename: Anna
authors.initials: A
authors.lastname: Merino
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000744:Anemia, Hemolytic, Autoimmune / Q000276:immunology* / Q000473:pathology / Q000628:therapy / Q000821:virology; D015551:Autoimmunity / Q000187:drug effects; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D057899:Cytophagocytosis / Q000187:drug effects; D004359:Drug Therapy, Combination; D016731:Erythema Infectiosum / Q000276:immunology* / Q000473:pathology / Q000628:therapy / Q000821:virology; D004912:Erythrocytes / Q000187:drug effects / Q000276:immunology / Q000473:pathology / Q000821:virology; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007155:Immunologic Factors / Q000627:therapeutic use; D008297:Male; D009000:Monocytes / Q000187:drug effects / Q000276:immunology* / Q000473:pathology / Q000821:virology; D009504:Neutrophils / Q000187:drug effects / Q000276:immunology* / Q000473:pathology / Q000821:virology; D016732:Parvovirus B19, Human / Q000187:drug effects / Q000276:immunology*; D000069283:Rituximab / Q000627:therapeutic use; D016511:Severe Combined Immunodeficiency / Q000276:immunology / Q000473:pathology / Q000628:therapy / Q000821:virology; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D000069283:Rituximab; D003520:Cyclophosphamide